Press release
Lung Cancer Therapeutics Market Size, Share, Key Players Overview and Geographical Outlook 2026
Lung cancer is considered one of the leading causes of death by cancer. Cancer can be a result of continuous exposure to asbestos, and unhealthy lifestyle that includes habits such as pipe smoking, cigarette smoking, cigar smoking. The rising incidence of lung cancer is subsequently fuelling demand for various therapies in the global lung cancer therapeutics market.
Browse Complete Report:
https://www.fortunebusinessinsights.com/industry-reports/lung-cancer-therapeutics-market-100473
Key companies covered in the Lung Cancer Therapeutics Market Research report include
• Astellas Pharma US
• Celgene
• Merck Sharp & Dohme GmbH
• Pfizer
• Eli Lilly and Company
• Bristol-Myers Squibb
• AstraZeneca
• Boehringer Ingelheim Pharmaceutical, Takeda
• Novartis
• Sanofi.
Targeted therapy is expected to emerge dominant among other therapies such as vaccine therapy, radiation therapy, chemotherapy, surgery, and immunotherapy. targeted therapy segment accounted for a share of 51.1% in the year 2018. This is because of the rise in focus towards the diagnosis of lung cancer and the positive outcome of targeted therapy that is increasing its demand in the global market.
However, the immunotherapy segment is anticipated to grow at the fastest CAGR during the forecast period. This is because of the rise in the number of product launches related to treating lung cancer. The availability of abundant resources is creating new opportunities for growth in the market during the coming years.
Get Sample PDF Brochure:
https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/lung-cancer-therapeutics-market-100473
Increasing Investments in Research and Development Activities to Boost Market
Various factors are responsible for boosting the global lung cancer therapeutics market. One among them is the launch of cancer awareness programs by both government and non-government organizations around the world. Cancer awareness and various treatment measures are increasing the demand for cancer therapeutics, especially in developing nations. Besides this, increasing investment by market players in research and development activities to discover novel therapeutics is driving the global market.
On the flip side, most of the anticipated drugs for lung cancer are still in their early testing stage and might take some time before finally getting launched in the market. This gestation gap between clinical trial and final launch might create uncertainty among players, making them skeptical about further investments in lung cancer treatment researches. This may hamper the market growth during the forecast period.
Furthermore, Cure for a certain type of cancer is yet to be discovered. The cure is yet to be discovered as targeted therapies have no effect on such cancer types. This is more likely to create challenges for the global market for lung cancer therapeutics during the forecast period.
The Asia Pacific to Emerge as the Fastest Growing Region with Rising in Cancer Awareness Programs
North America is expected to dominate the global market for lung cancer therapeutics. In 2018 the region generated a revenue of US$ 8,093.2 Mn. Growth in this region is attributable to the rising prevalence and diagnostics of lung cancer and the increasing adoption of advanced lung cancer therapeutics. Besides this, increasing awareness about cancer is enabling the market in Asia Pacific exhibit a faster CAGR.
A few novel therapeutics are introduced in the market, impelling leading players to research on improved medication. For instance, Genentech, a company operating in the lung cancer therapeutics market has recently launched their new drug named, Alecensa (alectinib), in order to treat ALK-positive non-small cell lung cancer. Such strategies adopted by players will bode well for the global lung cancer therapeutics market in the long run.
Global Lung Cancer Therapeutics Market Segmentation
By Therapy
• Targeted Therapy
o Bevacizumab
o Dabrafenib/Trametinib
o Erlotinib Hydrochloride
o Osimertinib
o Others
• Immunotherapy
o Durvalumab
o Nivolumab
o Atezolizumab
o Pembrolizumab
• Chemotherapy
By Cancer Type
• Non-small cell lung cancer (NSCLC)
• Small cell lung cancer (SCLC)
By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Others
Get Discount:
https://www.fortunebusinessinsights.com/enquiry/check-discount/lung-cancer-therapeutics-market-100473
KEY QUESTIONS ANSWERED:
What is the market size and growth rate of the global and regional market by various segments?
What is the market size and growth rate of the market for selective countries?
Which region or sub-segment is expected to drive the market in the forecast period?
What Factors are estimated to drive and restrain the market growth?
What are the key technological and market trends shaping the market?
What are the key opportunities in the market?
What are the key companies operating in the market?
Which company accounted for the highest market share?
Why Choose Fortune Business Insights?
Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Lung Cancer Therapeutics Market Size, Share, Key Players Overview and Geographical Outlook 2026 here
News-ID: 1841892 • Views: …
More Releases from Fortune Business Insights Pvt Ltd
Commercial Drone Market Size, Share, Industry Development, Growth & Trends by 20 …
The global commercial drone market size was valued at USD 8.77 billion in 2022. The market is projected to grow from USD 10.98 billion in 2023 to USD 54.81 billion by 2030, exhibiting a CAGR of 25.82% during the forecast period. A drone, also known as an unmanned aerial vehicle, is a flying device, equipped with a camera and sensor. Different industries are investing in drone technology and trying to…
Aircraft Engine Market Latest Key Drivers and Future Demand Forecast by 2029
According to a recent report by Fortune Business Insights, the global Aircraft Engine Market is expected to reach a size of USD 112.61 billion by 2028, growing at a CAGR of 10.87% during the forecast period 2021-2028. The report offers a thorough analysis of the market size, regional landscape, revenue forecasts, and upcoming challenges in the market. It also provides current statistics and future predictions, aiming to evaluate growth prospects,…
Space Mining Market the Development Strategies Adopted by Major Key Players And …
The increasing investments by mining companies is expected to foster healthy growth of the market during the forecast period, sates Fortune Business Insights in a report, titled "Space Mining Market Size, Share & Industry Analysis, By Phase (Spacecraft Design, Launch, Operation), By Asteroid type (Type C, Type S, Type M, Others), By Application (Construction, Resource Harvesting, 3D Printing, Others) and Regional Forecast, 2023-2030." The growing number of government initiatives for…
Radar Level Transmitter Market Size, Gross Margin, Trends, Future Demand, Analys …
The higher level of accuracy, reliability, and stability offered by radar level transmitters is expected to fuel the demand of the market during the forecast period, states Fortune Business Insights, in a report, titled "Radar Level Transmitter Market Size, Share & Industry Analysis, By Technology (Contact, Noncontact), By Frequency Range (C and X Band, W Band, K Band), By Application (Liquids, slurries, and interfaces, Solids), By Industry (Oil & Gas,…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
